Home/Filings/4/0001578563-22-000022
4//SEC Filing

KAPLAN GILLA 4

Accession 0001578563-22-000022

CIK 0001534120other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:30 PM ET

Size

5.4 KB

Accession

0001578563-22-000022

Insider Transaction Report

Form 4
Period: 2022-06-14
KAPLAN GILLA
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-14+40,00040,000 total
    Exercise: $0.44From: 2023-06-14Exp: 2032-06-14Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest in full on June 14, 2023, subject to the Reporting Person's continued service on such vesting date.

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1
  • filerCIK 0001247024

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:30 PM ET
Size
5.4 KB